IMO the impact of the drugs should be, more than preventing deaths, in reducing hospitalization or even prevent going into the ICU, which can mean removing load

IMO the impact of the drugs should be, more than preventing deaths, in reducing hospitalization or even prevent going into the ICU, which can mean removing load off the healthcare system and make infections manageable (far more than waiting out for a vaccine). In fact, some the remdesivir trials which will end next month (end of April) measure also the time spent in the hospital.